User: Guest  Login
Title:

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

Document type:
Journal Article; Review
Author(s):
Drexler, I; Staib, C; Sutter, G
Abstract:
Safety-tested modified vaccinia virus Ankara (MVA) has been established as a potent vector system for the development of candidate recombinant vaccines. The versatility of the vector system was recently demonstrated by the rapid production of experimental MVA vaccines for immunization against severe acute respiratory syndrome associated coronavirus. Promising results were also obtained in the delivery of Epstein-Barr virus or human cytomegalovirus antigens and from the clinical testing of MVA ve...     »
Journal title abbreviation:
Curr Opin Biotechnol
Year:
2004
Journal volume:
15
Journal issue:
6
Pages contribution:
506-12
Language:
eng
Fulltext / DOI:
doi:10.1016/j.copbio.2004.09.001
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/15560976
Print-ISSN:
0958-1669
TUM Institution:
Institut für Virologie
 BibTeX